I am a lipid biochemist-cell biologist determining the molecular mechanisms of disorders of lipid metabolism and developing treatments for such disorders. The diseases where lipid metabolism plays a key role include cardiovascular diseases (such as coronary artery disease), metabolic disorders (such as diabetes), some infectious diseases (such as HIV) and neurological disorders (such as Alzheimer disease).
I conduct epidemiological research on illicit drug use and harm, with a particular focus upon surveillance of drug use disorders and morbidity in sentinel populations. My epidemiological research has focused particularly on the comorbidity between drug de
David Whiteman is a medical epidemiologist with a special interest in the causes, diagnosis, prevention and treatment of cancer. His work has focussed on melanoma and skin cancer, and more recently, on cancers of the upper gastro-intestinal tract.
I am an epidemiologist, primarily interested in the study and quantitative assessment of the environment-health relationship. Specifically, my current research focuses on development of innovative methods to assess the impact of ecosystem change (eg, clim
I am a molecular epidemiologist, studying the environmental and genetic causes of cancer, particularly endometrial and breast cancer. I am studying the molecular markers that act as signatures for the environmental and-or genetic aetiology of a given canc
I conduct and collaborate in randomized trials and observational cohort studies evaluating the toxicities (types, pathogenesis, risk factors, treatment and prevention) of HIV antiretroviral therapy. In particular, I study the main metabolic complications
With particular interest in developing data analysis techniques, I am an epidemiologist assessing risk factors and developing risk calculators for non-communicable diseases, such as cardiovascular disease and diabetes, in Aboriginal people.